Bio4Comp the new EU Research Project we are involved in, as presented by LABIOTECH.eu Better than Quantum Computing: The EU Launches a Biocomputer Project
Biomolecular machines exploring nano-fabricated networks is the core research of Bio4Comp Project on the very futuristic field of Biocomputers. Molecular Sense is further involved in this new Project, which continues the succesful work carried under Abacus Project. Bio4Comp has received funding from the European Union’s Horizon 2020 research and nnovation programme under
TTI/Vanguard is the advanced technology conference series for senior-level executives. TTI/Vanguard’s member organizations represent global private, public, and academic sectors. TTI/Vanguard introduce, discuss, and evaluate emerging and breakthrough technologies on the two-to-five-year horizon. Through conferences, workshops, and field trips, experts offer perspectives on future technologies and their impact on organizations, infrastructures,
Our research result on biocomputation is presented in the prestigious American publication Smithsonian Magazine, May 2016 edition.
Molecular Sense Ltd. based in England, which is a research-intensive company founded by two scientists Dan and Dan Nicolau, father and son, develops technologies, both soft and hard in the emerging areas of intelligent processing of biological information. Creating new methodologies for molecular surfaces – relevant to drug discovery, and